Tilray Medical Supports Scientific Study on Fibromyalgia With Positive Outcomes: Effectiveness of Cannabinoids Treatment in Pain Management and Other Fibromyalgia-Associated Symptoms
09 sept. 2024 07h00 HE
|
Tilray Brands, Inc.
LISBON, Portugal, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the...
World Cannabis Market Report 2024: Examining Five Drivers Shaping Legal Cannabis
06 sept. 2024 05h22 HE
|
Research and Markets
Dublin, Sept. 06, 2024 (GLOBE NEWSWIRE) -- The "World Market for Cannabis" report has been added to ResearchAndMarkets.com's offering. Backed partly by existing legacy use, there is a broad-based...
Europe Medical Cannabis Market Forecast 2024-2032: Tilray, Aurora Cannabis, and GW Pharmaceuticals Dominate the Market Landscape
29 août 2024 05h12 HE
|
Research and Markets
Dublin, Aug. 29, 2024 (GLOBE NEWSWIRE) -- The "Europe Medical Cannabis Oil Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2024-2032." report has been added to ...
Australia Medical Cannabis Market Size, Share & Trends Analysis Report 2024-2030: Entry Of International Players, Consumer Shift in Education, Increasing Preference for Oils and Tinctures
13 août 2024 10h27 HE
|
Research and Markets
Dublin, Aug. 13, 2024 (GLOBE NEWSWIRE) -- The "Australia Medical Cannabis Market Size, Share & Trends Analysis Report by Application (Cancer, AIDS), Sources (Hemp, Marijuana), Derivatives (CBD,...
Germany Legal Cannabis Market Analysis 2024-2030 by Source (Hemp, Marijuana), Derivatives (CBD, THC)
12 août 2024 09h28 HE
|
Research and Markets
Dublin, Aug. 12, 2024 (GLOBE NEWSWIRE) -- The "Germany Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Hemp, Marijuana), Derivatives (CBD, THC), End-use, and Segment...
Australia Legal Cannabis Market 2024-2030 by Source (Marijuana, Hemp), Derivative (CBD, THC), End-use (Medical Use, Recreational Use, Industrial Use) Size, Share & Trends Analysis
09 août 2024 04h34 HE
|
Research and Markets
Dublin, Aug. 09, 2024 (GLOBE NEWSWIRE) -- The "Australia Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Marijuana, Hemp), Derivative (CBD, THC), End-use (Medical Use,...
Tilray Medical Announces Scientific Study on Medical Cannabis for Patients Over Age 50
09 juil. 2024 07h00 HE
|
Tilray Brands, Inc.
Tilray-led scientific publication examines the real-world impact of medical cannabis use on patients over the age of 50.
Tilray Medical Launches Broken Coast Medical Cannabis Brand in Australia
20 juin 2024 07h00 HE
|
Tilray Brands, Inc.
Tilray's Broken Coast EU-GMP Certified Medical Cannabis Whole Flower Products Are Now Available through a Doctor’s Prescription in Australia
Global Cannabis Pharmaceuticals Market Analysis Report 2024-2030, with Key Player Profiles for Canopy Growth Corporation, Jazz Pharmaceuticals, AbbVie, Insys Therapeutics and Bausch Health
11 juin 2024 07h51 HE
|
Research and Markets
Dublin, June 11, 2024 (GLOBE NEWSWIRE) -- The "Global Cannabis Pharmaceuticals Market Size, Share & Trends Analysis Report by Brand Type (Sativex, Epidiolex, Other Brands), Region (North...
2024 World CBD Regulatory Database with Extensive Delta-8 THC Regulatory Coverage
10 juin 2024 08h40 HE
|
Research and Markets
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Global CBD Regulatory Database" has been added to ResearchAndMarkets.com's offering. This database bundle provide essential information about how...